• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

PEPFAR drugs (NDAs) cumulative approvals and tentative approvals since 2004

Dictionary: PEPFAR applications are marketing applications for single entity, fixed dose combination (FDC), and co-packaged versions of previously approved antiretroviral therapies for the treatment of AIDS. The initiative includes an expedited review process and ensures that safe, effective, and quality manufactured antiretroviral drugs are available in global areas of need.

Information is current as of December 31, 2013.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber
Oct 2011N/AN/A
Nov 2011N/AN/A
Dec 2011N/AN/A
Jan 2012N/AN/A
Feb 2012N/AN/A
Mar 2012N/AN/A
Apr 2012N/AN/A
May 2012N/AN/A
Jun 2012N/AN/A
Jul 2012N/A55
Aug 2012N/A55
Sep 2012N/A56

FY 2012 3 month Total: 56

Footnotes

  • CDER created new measures and began collecting data in July 2012. Therefore, FY12 will only include 3 months of data.

PEPFAR drugs (ANDAs) cumulative approvals and tentative approvals since 2004

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber
Oct 2011N/AN/A
Nov 2011N/AN/A
Dec 2011N/AN/A
Jan 2012N/AN/A
Feb 2012N/AN/A
Mar 2012N/AN/A
Apr 2012N/AN/A
May 2012N/AN/A
Jun 2012N/AN/A
Jul 2012N/A98
Aug 2012N/A98
Sep 2012N/A98

FY 2012 3 month Total: 98

Footnotes

  • CDER created new measures and began collecting data in July 2012. Therefore, FY12 will only include 3 months of data.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.